FONAR Co. (NASDAQ:FONR – Get Free Report) saw a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 12,900 shares, a decline of 5.8% from the August 15th total of 13,700 shares. Based on an average daily trading volume, of 12,200 shares, the short-interest ratio is presently 1.1 days. Approximately 0.2% of the company’s stock are short sold.
Wall Street Analyst Weigh In
Separately, StockNews.com downgraded FONAR from a “strong-buy” rating to a “buy” rating in a research note on Tuesday.
View Our Latest Analysis on FONAR
Institutional Trading of FONAR
FONAR Stock Down 0.9 %
Shares of FONR stock opened at $17.40 on Thursday. FONAR has a 12 month low of $12.13 and a 12 month high of $24.05. The company has a market cap of $110.11 million, a PE ratio of 11.15 and a beta of 1.19. The business’s 50 day moving average is $17.24 and its two-hundred day moving average is $17.47.
About FONAR
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Read More
- Five stocks we like better than FONAR
- Want to Profit on the Downtrend? Downtrends, Explained.
- How Much Can You Make in Stocks in One Month?
- How to Invest in Biotech Stocks
- This Is the Top Large-Cap Stock Insiders Are Buying
- How to Use the MarketBeat Stock Screener
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for FONAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FONAR and related companies with MarketBeat.com's FREE daily email newsletter.